Dr. Liu is Professor and Director of Vascular Research Laboratory at Department of Surgery, University of Miami Miller School of Medicine. He is also the Associate Director of Vascular Biology Institute. He obtained his PhD. from Osaka University, Japan. His research interests span both vascular biology and cancer biology. His interest in the field of vascular biology has focused on (1) development of gene- and stem cell-based therapy for therapeutic angiogenesis in regenerative medicine; (2) elucidating molecular mechanisms for atherosclerosis and vascular inflammation; and (3) investigating the signals and mechanisms underlying homing of endothelial progenitor cell (EPC) and mesenchymal stem cells (MSC) to wound, ischemia and tumor tissues.
In the field of cancer biology, his research is directed toward elucidation of how dysregulation of the Notch signaling pathway, both in the neoplastic cells and in the tumor stromal cells, leads to melanocytic transformation and melanoma progression. The major goal of his research in this part is to develop novel cancer therapy through targeting the Notch signaling pathway and its down-stream mediator(s), in cancer cells or in tumor microenvironment, for melanoma/cancer treatment. Dr. Liu’s researches are sponsored by federal grants from NIH and state of Florida biomedical research program funding. Dr. Liu has published 80+ research papers, review articles and book chapters.